Log In
BCIQ
Print this Print this
 

TricOs T

  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionBone void filler comprised of hydroxyapatite-coated beta tricalcium phosphate (HA/TCP) granules and a fibrin sealant
Molecular Target Fibrin
Mechanism of ActionSealant
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationBone repair
Indication DetailsBone void filler
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today